CAS 861875-60-7

NVP-BAW2881

Description:

NVP-BAW2881, identified by its CAS number 861875-60-7, is a synthetic compound that belongs to the class of small molecules. It is primarily recognized for its potential applications in medicinal chemistry and pharmacology, particularly in the context of drug development. The compound exhibits a specific chemical structure that contributes to its biological activity, often involving interactions with various biological targets. NVP-BAW2881 has been studied for its effects on certain pathways, which may include modulation of receptor activity or enzyme inhibition. As with many synthetic compounds, its characteristics include solubility in organic solvents, stability under specific conditions, and a defined melting point range. Safety and handling precautions are essential when working with this compound, as it may possess toxicological properties that require careful assessment. Overall, NVP-BAW2881 represents a significant interest in research settings, particularly for its potential therapeutic applications.

Formula: C₂₂H₁₅F₃N₄O₂

Synonyms:

• NVP-BAW2881
• NVP-BAW2881;NVP-BAW-2881;;NVP-BAW 2881
• CS-2238
• 1-Naphthalenecarboxamide, 6-[(2-amino-4-pyrimidinyl)oxy]-N-[3-(trifluoromethyl)phenyl]-
• 6-(2-amino-pyrimidin-4-yloxy)naphthalene-1-carboxylic acid (3-trifluoromethyl phenyl)amide
• 6-((2-aminopyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide
• BAW2881
• BAW2881 (NVP-BAW2881)

NVP-BAW2881

CAS: 861875-60-7

Formula: C₂₂H₁₅F₃N₄O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 424.3753

Ref: IN-DA00GUBF

NVP-BAW2881

CAS: 861875-60-7

NVP-BAW2881

Purity: ≥98%

Molecular weight: 424.38g/mol

Ref: 54-BUP07095

NVP-BAW2881

CAS: 861875-60-7

NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor with activity to inhibit chronic and acute skin inflammation.

Formula: C₂₂H₁₅F₃N₄O₂

Purity: 98.19% - 99.97%

Color and Shape: Solid

Molecular weight: 424.38

Ref: TM-T3641

BAW 2881

CAS: 861875-60-7

BAW 2881 is a drug that has been shown to be effective in the treatment of cancerous growths. It inhibits angiogenesis by interfering with the synthesis of vascular endothelial growth factor (VEGF), which is necessary for the formation of new blood vessels. BAW 2881 also inhibits proliferation, migration, and adhesion of tumor cells. The drug has been found to inhibit angiogenesis in mice with choroidal neovascularization induced by laser photocoagulation. In addition, it has been shown to inhibit tumor growth without toxicity in a number of animal models, including carcinogenesis induced by DMBA or TPA and epithelial cancers induced by methylcholanthrene or TPA. BAW 2881 also inhibits tumor cell proliferation and migration as well as angiogenesis in cell culture studies.

Formula: C₂₂H₁₅F₃N₄O₂

Purity: Min. 95%

Molecular weight: 424.38 g/mol

Ref: 3D-LJB87560